| Literature DB >> 16414011 |
Akikazu Sakudo1, Yoshikazu Suganuma, Takanori Kobayashi, Takashi Onodera, Kazuyoshi Ikuta.
Abstract
Although several methods, including enzyme-linked immunosorbent assay, polymerase chain reaction, immunofluorescent assay, and Western blotting, have been used for the diagnosis of viral infections, none of them is ideal in terms of cost-effectiveness, speed, and accuracy. Currently, the rate of outbreak of emerging viruses is increasing and therefore the development and establishment of analytical methods for such viral infections are becoming more important. Near-infrared (NIR) spectroscopy is a fast, multicomponent assay that enables non-invasive, non-destructive analysis. Recently, the diagnosis of viral infections using NIR spectroscopy has been attempted. In this review, the potential of the NIR method in the medical and virological fields is discussed.Entities:
Mesh:
Year: 2006 PMID: 16414011 PMCID: PMC7092872 DOI: 10.1016/j.bbrc.2005.12.153
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575
Fig. 1(a) NIR calibration flowchart for viral infections. The process for establishing an NIR calibration model for viral infections is shown. Samples from healthy donors and individuals infected with virus are subjected to analyses by the reference method and NIR spectroscopy. After the collection of NIR spectra, the spectral data are pre-processed and subjected to quantitative or qualitative calibration modeling to develop a multivariate model to evaluate viral infection or virus load, which is measured by the reference method. For the development of a quantitative model, regression analyses such as partial least-squares regression analysis (PLS) and principal component regression analysis (PCRA) are used. For the qualitative model, clustering, and classification methods such as principal component analyses (PCA) and soft independent modeling of class analogy (SIMCA) are used. The model is confirmed by validation methods such as leave-out cross-validation. If the model is not acceptable, re-calibration is performed after the validation. The NIR model can be used for spectroscopic characterization of viruses as well as diagnostic tests of viral infection. Spectroscopic characterization is discussed from the model based on the NIR spectra of samples from virus-infected individuals and healthy donors. (A) Three consecutive spectra of plasma samples from an HIV-1-infected individual [red lines: HIV-1 p24 ELISA (−), HIV-1 PCR (+); green lines: HIV-1 p24 ELISA (+), HIV-1 PCR (+)] and a healthy donor (blue lines). (B) (i) PLS calibration model for estimating the HIV-1 p24 concentration of 12 subjects. Cross-validation model: 7 PLS factors based on the 600–1000 nm spectral region; R = 0.8555, standard error of cross-validation (SECV) = 23.33 pg/ml, standard deviation (SD) = 43.30 pg/ml, SD/SECV = 1.856 using a leave-out cross-validation procedure for HIV-1-infected individuals [red triangles: HIV-1 p24 ELISA (−), HIV-1 PCR (+); green diamonds: HIV-1 p24 ELISA (+), HIV-1 PCR (+)] and healthy donors (blue squares). (ii) PCA (first two principal components) for 12 subjects. PCA score plot of first principal component (PC1) versus second principal component (PC2) for plasma from HIV-1-infected individuals [red triangles: HIV-1 p24 ELISA (−), HIV-1 PCR (+); green diamonds: HIV-1 p24 ELISA (+), HIV-1 PCR (+)] and healthy donors (blue squares). (C) Regression coefficient for the model based on the spectra in the 600–1000 nm region of plasma from HIV-1-infected individuals and healthy donors shown in (B) (i). (D) After development of the model, NIR spectroscopy is rapid and requires no reagents for the analysis. Moreover, in principle, NIR spectroscopy can be used for the detection of viral infections in target cells, animals, and individuals after development of the model calculated from the spectra of virus-infected and non-infected cells, animals, and individuals. Thus, further study is necessary to establish an NIR model for various viral infections in various types of samples as another additional method of analysis in addition to ELISA and PCR. NIR spectroscopy may be also applied for diagnosis of infections by other viruses such as hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell lymphotropic virus (HTLV), and emerging viruses. If NIR spectroscopy proves to be able to sensitively discriminate different viral infections, NIR spectroscopy would become a promising diagnostic tool for addressing the issues of blood supply safety and emerging virus outbreaks. Modified from Figs. 2, 3, and 5 in Sakudo et al. [17] with permission from Center for Academic Publications Japan. (b) NIR spectroscopy coupled with proteomics may provide a powerful exploratory tool. High-performance liquid chromatography (HPLC), two-dimensional electrophoresis (2D-PAGE), and mass spectrometry (MS) constitute traditional analytical tools in classical proteomics. Samples are fractionated by HPLC using several columns. 2D-PAGE separates proteins based on acidity and molecular mass to reveal characteristics of the samples. MS is used for the identification of proteins. NIR spectrometry combined with multivariate analysis can be used for identification of the spectroscopic signature and may be used for further identification of proteins based on fractionation and band assignments. NIR spectroscopy coupled with HPLC, 2D-PAGE, and MS analysis may provide a powerful exploratory tool for the new era of proteomics.